Generics Industry News Search
 |
|
|
|
|
|
|
December 2012 News Archive |
|
|
| |
|
Under the partnership agreement, Lilly will have the rights to market cancer medicines across the emerging markets...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Mylan today announced that its subsidiary Mylan Pharmaceuticals has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Candesartan cilexetil and Hydrochlorothiazide tablets, 16/12.5 mg, 32/12.5 mg and 32/25 mg...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
The Swiss drug maker Novartis had been bracing all year for the day in late September when Diovan, its top-selling blood pressure drug, would lose patent protection and a cheaper generic version would become available...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Lotus Pharmaceutical has confirmed its submission of Abbreviated New Drug Application for Orlistat capsules...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
ACETO, a global leader in the marketing, sale and distribution of products for Human Health, Pharmaceutical Ingredients and Performance Chemicals, today announced that Rising Pharmaceuticals, its finished dosage form generics subsidiary, launched the first generic version of the 500 mg strength (microsize) of Griseofulvin tablets USP, an FDA approved generic version of Valeant Pharmaceutical's Grifulvin V...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
AstraZeneca announced today that the Court of Appeals for the Federal Circuit has upheld the decision of the District Court, District of Delaware, finding that the US substance patent protecting Crestor (Rosuvastatin calcium) (RE37,314 - the '314 patent) is valid and enforceable...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Teva Pharmaceutical (TEVA) and Handok Pharmaceuticals announced today their agreement to establish a business venture in South Korea, allowing Teva to gain entrance into the Korean pharmaceutical market, currently valued at approximately USD 14 billion...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Sun Pharmaceutical Industries announced today that Caraco Pharmaceutical Laboratories, its wholly-owned subsidiary, has entered into a definitive agreement with Takeda Pharmaceuticals U.S.A., a wholly-owned subsidiary of Takeda Pharmaceutical Company Limited, to buy the URL Pharma generic business...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Mylan today announced that its subsidiary Mylan Pharmaceuticals has received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application (ANDA) for Quinine sulfate capsules USP, 324 mg...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Breckenridge Pharmaceutical announced today the immediate launch of prescription Lansoprazole delayed-release capsules...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Mylan today announced that its subsidiary Mylan Pharmaceuticals has entered into a settlement agreement with Orion that will resolve patent litigation related to Entacapone tablets, 200 mg...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Acura Pharmaceuticals today announced that an Investigational New Drug application (IND) has been filed with the U.S. Food and Drug Administration (FDA) to allow clinical testing of Acura's Hydrocodone bitartrate with Acetaminophen formulated with Aversion Technology...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
U.S.-based drug maker Bristol-Myers Squibb has filed a patent infringement case against Dr. Reddy's Laboratories (DRL) over cancer drug Ixempra...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Mylan's lawsuit against the U.S. Food and Drug Administration for withholding approval for the company to sell a generic version of Novartis AG's heart pill Diovan was dismissed by a federal judge in Washington...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Watson Pharmaceuticals, today confirmed that Actavis which was acquired by Watson in October, has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market Bortezomib...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Mylan today announced that its partner Famy Care has received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for Levonorgestrel and Ethinyl Estradiol tablets USP, 0.15 mg/0.03 mg...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Mylan today announced that its subsidiary Mylan Pharmaceuticals has received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for Phenytoin chewable tablets USP, 50 mg...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Janssen Therapeutics, Division of Janssen Products, today announced the U.S. Food and Drug Administration (FDA) has granted accelerated approval to Sirturo (Bedaquiline) tablets for the treatment of pulmonary multi-drug resistant tuberculosis (MDR-TB) as part of combination therapy in adults...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Watson Pharmaceuticals, a leading specialty pharmaceutical company, announced today it has launched Clarithromycin extended-release tablets, USP in the 500 mg strength. Watson's Clarithromycin extended-release product is the generic equivalent to Abbott's Biaxin XL, which is indicated to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Mallinckrodt, the Pharmaceuticals business of Covidien, today announced that it has received approval from the U.S. Food and Drug Administration to manufacture and market a generic version of Concerta (Methylphenidate HCl) extended-release (ER) tablets USP in 27, 36 and 54 mg dosage strengths...
|
| |
|
|
Read more >>
|
| |
|
|
|
|
|
Contribute
If you would like to contribute or publish your
company press releases at GenericsWeb, please
email us.
|
Home
